Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
To subscribe to The Bloodline with LLS, click here.
Medical Marijuana & Cancer: What you Need to Know
Join us as we speak with Shelly Rosenfeld, Esq. from the Cancer Legal Resource Center and Dr. Steven Pergam from Seattle Cancer Care Alliance. Ms. Rosenfeld and Dr. Pergam presented at CancerCon during a session called, Understanding Medical Marijuana: It’s a Joint Effort. In this episode, our speakers dive into the various forms of marijuana, how they can be used to combat side effects of cancer treatment, and the legal issues surrounding their use throughout the United States.
Tackling Lymphoma: Recent Advances in Immunotherapy
Join us as we report on the latest developments in immunotherapy from the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition that was hosted virtually December 5-8, 2020. In this episode, we will be speaking to Dr. Laurie Sehn, a Clinical Professor and Researcher with the British Columbia Cancer Centre for Lymphoid Cancer and The University of British Columbia. Immunotherapy was a primary topic at this year’s ASH meeting. Dr. Sehn shares exciting news about the advancements in immunotherapy for Non-Hodgkin Lymphoma. Hear why lymphoma is a great candidate for immunotherapy, how it works, and how a collaboration of researchers from around the world is accelerating the number of new and effective treatments available for lymphoma patients.
Support for this episode provided by Genentech and Pharmacyclics.
Providing Hope for AML Patients
Join us as we speak to Dr. Courtney DiNardo from MD Anderson Cancer Center in Houston, TX. about the recent advancements in AML treatment. Dr. DiNardo is an academic clinical researcher who has participated in clinical trials resulting in three new AML therapies since 2017. In this episode, we dive into the new treatments that are showing great promise, as well as discuss how AML can be hereditary. With recent results of the Beat AML Master Clinical Trial, the increasing potential of immunotherapy and other new treatments, this episode is sure to give hope for current and future AML patients and caregivers.
Support for this episode provided by Novartis.
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the medical advice of your healthcare provider, information provided to you by your insurance carrier, or to provide legal advice with respect to the subject matter addressed in the podcast.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.